Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 23 papers were listed this time. Here's a few in our areas of research interest:
Zhu J, Li T, Wang X, et al. Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: an economic analysis. BMC Cancer. 2013 Jan 29;13(1):39. [Epub ahead of print] PubMed PMID: 23360224.
Rodríguez-Martínez CE, Sossa-Briceño MP, Castro-Rodriguez JA. Cost- Utility Analysis of the Inhaled Steroids Available in a Developing Country for the Management of Paediatric Patients with Persistent Asthma. J Asthma. 2013 Jan 28. [Epub ahead of print] PubMed PMID: 23356720.
Lintvedt OK, Griffiths KM, Eisemann M, et al. Evaluating the translation process of an internet-based self-help intervention for prevention of depression: a cost-effectiveness analysis. J Med Internet Res. 2013 Jan 23;15(1):e18. PubMed PMID: 23343481.
Wouters H, Thijs V, Annemans L. Cost-effectiveness of dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation in Belgium. J Med Econ. 2013 Jan 22. [Epub ahead of print] PubMed PMID: 23320796.
